Director and Senior Research ScientistUniversity at Albany, State University of New York
Psychology, Mental Health, Suicide Prevention, Alcohol, Drugs, Counseling, College Student Health, Social Justice, Disabilites
M. Dolores Cimini is a New York State licensed psychologist who has provided leadership for comprehensive efforts in research-to-practice translation at the University at Albany since 1992 with over $9 million in support from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Education, U.S. Department of Justice, and New York State Office of Addiction Services and Supports. The screening and brief intervention program developed by Dr. Cimini, the STEPS Comprehensive Alcohol Screening and Brief Intervention Program, has earned 13 national awards for best practices and innovation in behavioral health care. Cimini is the director of the Middle Earth Peer Assistance Program at UAlbany, an agency recognized as a model/exemplary program in alcohol and other drug prevention by both the U.S. Department of Education and the Center for Substance Abuse Prevention, U.S. Department of Health and Human Services. She has published two books and numerous professional articles in both national and international refereed journals in the alcohol and substance use field and has earned two awards for excellence from the White House for her contributions to STEM mentoring. Cimini is a member of the Commission on Accreditation of the American Psychological Association and was the Past Chair of the APA Board for the Advancement of Psychology in the Public Interest, where she has had leadership for reviewing and disseminating APA’s practice standards focused on serving diverse and underrepresented groups and the addressing of issues related to psychology and social justice.
Joseph J. Ciotola, M.D., is a top rated orthopedic surgeon at Orthopedics and Joint Replacement at Mercy Medical Center. Board Certified, Dr. Ciotola’s extensive expertise in anterior hip replacement makes him one of the most sought-after orthopedic surgeons in the Baltimore region for hip replacement. Dr. Ciotola also specializes in knee replacement and knee resurfacing using MAKO® robotic arm technology, ACL reconstruction and shoulder/upper extremity surgeries including total shoulder replacement and the LRTI procedure to relieve arthritis of the thumb. Dr. Joseph Ciotola’s dedication to providing advanced orthopedic techniques helped bring anterior hip replacement to Orthopedics and Joint Replacement at Mercy. Dr. Ciotola, who is one of the first orthopedic surgeons in Baltimore to perform anterior hip replacement, teaches orthopedic surgeons throughout the country how to perform this minimally invasive approach to hip replacement. Many of his patients have expressed their gratitude and satisfaction by recommending Dr. Ciotola to family, friends and even strangers who are in need of a hip replacement. Dr. Joseph Ciotola is dedicated to providing his patients the best orthopedic care possible. Patients turn to Dr. Ciotola for his clinical expertise when they have hip or knee pain. His great compassion and concern for helping relieve their pain provides patients with the confidence that they will be able to return to their daily routines. Dr. Ciotola works individually with patients to develop the best treatment options to help with the return to normal activities.
Kevin Cokley's research can be broadly categorized in the area of African American psychology, with a focus on racial and ethnic identity development, academic motivation, and academic achievement. A theme of much of his research is understanding the psychological and environmental factors that impact African American student achievement. Cokley's research and scholarship have led him to challenge the notion that African American students are anti-intellectual, and to critically re-examine the impact of racial and ethnic identity and gender on academic achievement. Recently Cokley has started exploring the impostor phenomenon and its relationship to mental health and academic outcomes among ethnic minority students. Cokley's publications have appeared in professional journals such as the Journal of Counseling Psychology, Journal of Black Psychology, Cultural Diversity and Ethnic Minority Psychology, Individual Differences and Personality, Measurement and Evaluation in Counseling and Development, the Journal of Multicultural Counseling and Development, Educational and Psychological Measurement, and the Harvard Educational Review. Cokley has a joint appointment in the College of Education's Department of Educational Psychology and the College of Liberal Arts' Department of African and African Diaspora Studies. He is the Past Editor-in-Chief of the Journal of Black Psychology and the Director of the Institute for Urban Policy Research & Analysis. He has written several Op-Eds in major media outlets including the St. Louis Post Dispatch, Dallas Morning News, San Antonio Express, The American Prospect, The Huffington Post, The Conversation and The Hill on topics such as Blacks' rational mistrust of police, police shootings of Blacks, the aftermath of Ferguson, the use of school vouchers, racial disparities in school discipline, and Black students' graduation rates.
Associate ProfessorUniversity at Albany, State University of New York
Tropical Cyclone, Hurricane, Cloud Behavior, Monsoons
Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center in Seattle. For more than four decades, he has led some of the most significant advances in medicine, including the development of safe and effective antivirals for herpes, HIV and hepatitis infections. An international expert in the design and testing of vaccines, he is helping to formulate a global, strategic response to COVID-19. Earlier this year, he responded to the sudden emergence of COVID-19 by redirecting his energies to speed the development of antiviral medications and vaccines against SARS-CoV-2, the virus responsible for the pandemic. He is building strategic collaborations among academic institutions, government health leaders and the pharmaceutical industry to test future COVID-19 vaccines and find ways to manufacture and distribute enough doses to immunize as many as 4 billion people. Dr. Corey is drawing on his expertise as a co-founder, in 1998, of the HIV Vaccine Trials Network. Headquartered at Fred Hutch in Seattle, it is the world’s largest publicly funded collaboration focused on development of vaccines to prevent HIV/AIDS. Dr. Corey's teaching and mentoring interests include virology, viral immunology and development of novel therapies for viral infections. His current research projects include: - Spatial and functional characterization of tissue resident immune responses at the site of herpesvirus or HIV infection - Development of immunotherapies for HSV and HIV infection; including CAR T cells for treatment for HIV infection - Spatial dynamics and function of adoptively transferred or vaccine induced T cells - Characterization of tissue-based memory B cells and the role antibody effector responses play in chronic viral infections - Use of monoclonal antibodies for the prevention of viral infections In addition to his role as president and director emeritus at Fred Hutch, Dr. Corey is a member of the Center's Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions. He is also a Professor, Medicine and Laboratory Medicine at the University of Washington, and Principal Investigator at the HIV Vaccine Trials Network (HVTN).
Dr. Costa's goal is to maximize survival and minimize morbidity for mechanically ventilated adults. She accomplishes this through her research on the organization and management of critical care. Specifically, her work identifies key structural and functional characteristics of ICU interprofessional teams that can be leveraged to improve the delivery of high quality, complex care to mechanically ventilated patients
I have been working at the VA Medical Center and in the Department of Behavioral Neuroscience at the Oregon Health & Science University in Portland since 1979. I entered graduate school at the University of Colorado to obtain a Ph.D. in social psychology. Fortuitously, I was sidetracked into instead studying behavioral neuroscience (AKA biopsychology) at the fledgling Institute for Behavioral Genetics in Boulder. I’ve been pretty much surrounded by mice ever since. I did post-doctoral work at the University of Wisconsin- Milwaukee and was a Lecturer in Psychology at San José State and then UC-Santa Barbara, and then held a two-year research position at a Dutch pharmaceutical company in the Dutch hinterlands before Portland. My research interest is in understanding individual differences in behavioral susceptibility to alcohol and other drugs of abuse, and their genetic and neurobiological bases. Most recently, I’ve been breeding mice that voluntarily drink alcohol until they become intoxicated, i.e. developing a mouse model of university students. I’m working with collaborators to figure out how many genes we’ve affected in the process, which ones they are, and what their biological functions are. We’re using that information to try to predict some drugs that are already FDA approved that might be re-purposed to try as treatments for alcoholism. My expertise is in mouse behavioral tests that try to capture human traits such as anxiety, sensitivity to drug’s rewarding or aversive effects, incoordination, learning and memory, novelty-seeking, and so forth. I am less fluent in rat than in mouse but the languages are related. I am familiar with psychiatric genetics/human genetics methods, but not really expert in the more esoteric of them. I am also familiar with the big data/genomics/informatics approaches, but again not really expert there, either.
Dr. Crutchfield, a nationally known expert on concussions and traumatic brain injury, directs LifeBridge Health’s Comprehensive Sports Concussion Program. He has served as an independent neurologist for many professional sports leagues and is board certified in psychiatry and neurology. He is a faculty appointee at the Uniformed Services University of Health Sciences and is a researcher and consultant to the U.S. military regarding the effects of traumatic brain injuries.
As the founding executive director of UCI’s multidisciplinary Cybersecurity Policy & Research Institute, Bryan Cunningham is focused on solution-oriented strategies that address technical, legal and policy challenges to combat cyber threats; protect individual privacy and civil liberties; maintain public safety, economic and national security; and empower Americans to take better control of their digital security. Cunningham is a leading international expert on cybersecurity law and policy, a former White House lawyer and adviser and a media commentator on cybersecurity, technology and surveillance issues. He has appeared on ABC, Bloomberg, CBS, CNN, FOX and other networks. Cunningham has extensive experience in senior U.S. government intelligence and law enforcement positions. He served as Deputy Legal Adviser to then-National Security Advisor Condoleezza Rice. He also served six years in the Clinton administration as a senior CIA officer and federal prosecutor. He drafted significant portions of the Homeland Security Act and related legislation, helping to shepherd them through Congress. He was a principal contributor to the first National Strategy to Secure Cyberspace, worked closely with the 9/11 Commission and provided legal advice to the President, National Security Advisor, the National Security Council, and other senior government officials on intelligence, terrorism, cyber security and other related matters. Cunningham is a founding partner of the Washington, DC-Los Angeles firm Cunningham Levy Muse, and his law practice has included assisting Fortune 500 and multinational companies to comply with complex legal regulations under U.S. federal law, myriad state laws and the numerous privacy and security requirements in the European Union and other overseas jurisdictions. He was founding vice-chair of the American Bar Association Cyber Security Privacy Task Force and was awarded the National Intelligence Medal of Achievement for his work on information issues. He has served on the National Academy of Sciences Committee on Biodefense Analysis, the Markle Foundation Task Force on National Security in the Information Age and the Bipartisan Policy Center’s Cyber Security Task Force. He is also the principal author of legal and ethics chapters in several cybersecurity textbooks.
Dr. Daadi is an expert in regulated translational research and has developed therapeutic neural stem cell lines (NSC) for clinical use in Parkinson’s disease, stroke, and to target brain tumors in both industrial and academic settings. He discovered a novel technique of engineering these stem cell lines from pluripotent human embryonic stem cells and continues to develop this therapeutic cell line for clinical use. Dr. Daadi came to Texas Biomed in 2014 and is the team leader for the SNPRC Regenerative Medicine and Aging research unit. Results from his studies are the foundation of translational research and help to repair diseased or injured brain through transplantation of highly purified NSCs and stimulation of internal repair mechanisms.
Population Health ExpertAnn and Robert H. Lurie Children's Hospital of Chicago
Child Health, Population Health, Child Health Policy, Medicaid, Vaccines, Lead Poisoning, Violence
Matthew Davis, MD, MAPP, is Division Head of Academic General Pediatrics and Primary Care at Ann & Robert H. Lurie Children’s Hospital of Chicago and Associate Chief Research Officer for Health Services and Policy Research at Stanley Manne Children's Research Institute at Lurie Children’s. He is a Professor of Pediatrics at Northwestern University Feinberg School of Medicine. His research focus is on population health, with particular emphasis on the family context and impact of local, state and federal policies on child and family health. Before coming to Lurie Children’s, Dr. Davis was at C.S. Mott Children’s Hospital in Michigan, where he was quoted often in the media as the expert on the impact of the Flint, Michigan water contamination crisis.
Lisa Delpy Neirotti is the director of the MS in Sport Management Program and an associate professor of Sport Management at the George Washington University School of Business (GWSB). She has been a professor of sport, event, and tourism management at the George Washington University for more than 28 years. Dr. Delpy Neirotti has established a strong academic program at both the undergraduate and graduate level and has also helped develop the Sport Philanthropy Certificate, which serves to increase the efficiency and effectiveness of non-profit organizations using sport for social good. She also directs the GW Green Sports Scorecard to help increase the sustainability of sport facilities, organizations and events, and serves on the faculty of the International Olympic Committee’s Executive Master's In Management of Sports Organizations (MEMOS). Beyond her responsibilities at GW, Dr. Delpy Neirotti works with a number of sport event organizations, sponsors, and professional teams to conduct economic and market research studies including the Olympic Games, World Cup, BNP Paribas Open, Citi Bank Tennis Tournament, Rock and Roll Marathon, Marine Corp Marathon, College Football Bowl Games, among others. As a pioneer in the field of sports tourism, Dr. Delpy Neirotti founded the annual TEAMS: Travel, Events, and Management in Sports conference. Since 1997, TEAMS serves to define, develop and expand the fast growing field of Sports Tourism. Numerous organizations including USAID have commissioned her to look at sport tourism as an economic development tool. Dr. Delpy Neirotti co-authored The Ultimate Guide to Sport Event Management and Marketing and serves on the editorial board of SportsTravel magazine. She also is a member of the Women’s Sport Foundation (WSF), Up2Us, and Council for Responsible Sports advisory boards as well as Vice-President of the DC Chapter of Women In Sports and Events (WISE). Prior to arriving at the George Washington University, Dr. Delpy Neirotti traveled to 56 countries around the world studying the development and organization of the Olympic Movement. Since 1984, she has attended 19 consecutive Olympic Games, 5 World Cups, and hundreds of other major sport events as a consultant, volunteer or researcher. In 2004, she served on the World Cup host committee in Washington, DC. Born and raised in California, Dr. Delpy Neirotti received her undergraduate degree from California Polytechnic State University, San Luis Obispo; a MS in Sport Management from George Mason University, Fairfax, VA; and a Ph.D. in Sport Administration from the University of New Mexico in Albuquerque. Her doctoral dissertation was on the organizational structure and effectiveness of the U.S. national sport governing bodies.
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory Medicine and Pediatrics, Associate Professor of Preventive Medicine and Community Health and Assistant Dean for Research in Health Policy at the New Jersey Medical School, Newark, New Jersey. He has served on numerous committees for the NIH over the last two decades and currently is the principal investigator of an NIH portfolio in excess of 56 million dollars. Mr. Denny was a 2002-2003 Robert Wood Johnson Foundation Health Policy Fellow at the Institute of Medicine of the National Academies (IOM). As a fellow, he served on the US Senate Health, Education, Labor and Pensions Committee with legislation/policy responsibilities in global AIDS, bioterrorism, clinical trials/human subject protection and vaccine related-issues.
A former teacher in elementary school, Pierre Dillenbourg graduated in educational science (University of Mons, Belgium). He started his research on learning technologies in 1984. He obtained a PhD in computer science from the University of Lancaster (UK), in the domain of artificial intelligence applications for education. He has been assistant professor at the University of Geneva. He joined EPFL in 2002. He has been the academic director of Center for Digital Education, which implements the MOOC strategy of EPFL (over 2 million registrations). He is full professor in learning technologies in the School of Computer & Communication Sciences, where he is the head of the CHILI Lab: "Computer-Human Interaction for Learning & Instruction". He is the director of the leading house DUAL-T, which develops technologies for dual vocational education systems (carpenters, florists,...). With EPFL colleagues, he launched in 2017 the Swiss EdTech Collider, an incubator with 80 start-ups in learning technologies. In 2018, he co-founded LEARN, the EPFL Center of Learning Sciences that brings together the local initiatives in educational innovation. He is a fellow of the International Society for Learning Sciences.
The founding director of the Business, Education and Community Outreach Network (BEACON) in Salisbury University’s Franklin P. Perdue School of Business, Dr. Memo Diriker is an economic trend analysist with expertise in healthcare policy and economics, as well as local and state government economics. Through BEACON, he also has overseen analyses on growing regional Hispanic and elderly populations, as well as the economic benefits of agriculture. BEACON, The Business Economic and Community Outreach Network, of the Franklin P. Perdue School of Business at Salisbury University, offers business, economic, workforce, and community development consulting and assistance services to a variety of organizations, including businesses, government agencies, and non-profit community-based organizations. At BEACON, Diriker advises a large number of private, public, and nonprofit sector organizations, specializing in the use of scenario analysis and in demographic, business and economic trend forecasting. He oversees the organization’s initiatives, including Bienvenidos a Delmarva, ShoreENERGY, GrayShore and ShoreTrends. He has served as the principal investigator on numerous grants and sponsored research projects, totaling over $10 million in awards. In addition to a book, he has authored many articles in academic and practitioner publications, and is a sought-after public speaker.